Ausgabe 3/2020
Inhalt (14 Artikel)
Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy
Tingjuan Ni, Na Lin, Wenqiang Lu, Zhenzhu Sun, Hui Lin, Jufang Chi, Hangyuan Guo
The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species
Martin Stroethoff, Lukas Goetze, Carolin Torregroza, Sebastian Bunte, Annika Raupach, André Heinen, Alexander Mathes, Markus W. Hollmann, Ragnar Huhn
Effects of Sodium–Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction
Salva R. Yurista, Herman H. W. Silljé, Harry van Goor, Jan-Luuk Hillebrands, Hiddo J. L. Heerspink, Luiz de Menezes Montenegro, Silke U. Oberdorf-Maass, Rudolf A. de Boer, B. Daan Westenbrink
Ibutilide Reduces Ventricular Defibrillation Threshold and Organizes Ventricular Fibrillation Activation in Canine Heart Failure Model
Ning Zhang, Qingzhi Luo, Qi Jin, Yanxin Han, Shangwei Huang, Yue Wei, Changjian Lin, Kang Chen, Weifeng Shen, Liqun Wu
Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease
Florian Krackhardt, Matthias Waliszewski, Viktor Kočka, Petr Toušek, Bronislav Janek, Martin Hudec, Fernando Lozano, Koldobika Garcia-San Roman, Bruno Garcia del Blanco, Josepa Mauri, Tay Mok Heang, Tae Hoon Ahn, Myung Ho Jeong, Denny Herberger, Vjekoslav Tomulic, Gilles Levy, Laurent Sebagh, Jérôme Rischner, Michel Pansieri
A Common Missense Variant in OMA1 Associated with the Prognosis of Heart Failure
Dong Hu, Shiyang Li, Senlin Hu, Yang Sun, Lei Xiao, Chenze Li, Jing Wang, Yan Wang, Li Ni, Chunxia Zhao, Dao Wen Wang
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P. Judge, Arnt V. Kristen, Martha Grogan, Mathew S. Maurer, Rodney H. Falk, Mazen Hanna, Julian Gillmore, Pushkal Garg, Akshay K. Vaishnaw, Jamie Harrop, Christine Powell, Verena Karsten, Xiaoping Zhang, Marianne T. Sweetser, John Vest, Philip N. Hawkins
Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation
Pingping Yang, Chenxi Wang, Yinquan Ye, Tieqiu Huang, Shuai Yang, Wen Shen, Gaosi Xu, Qinghua Wu
Beneficial Effect of Flecainide Controlled Release on the Quality of Life of Patients with Atrial Fibrillation—the REFLEC-CR Study
Stylianos Tzeis, Dimitrios Tsiachris, Dimitrios Asvestas, Spiridon Kourouklis, Fotios Patsourakos, Dimitrios Karlis, George Kouskos, George Papadimitriou, Marianna Gavriilidou, Nikolaos Vatkalis, Konstantinos Kapetanios, Panagiota Koufaki, Efstathios Taxiarchou, George Giannakoulas
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Peripheral Artery Disease: a Systematic Review and Meta-Analysis
Xiang-Zhong Liao, Yong-Hui Fu, Jian-Yong Ma, Wen-Gen Zhu, Ping Yuan
Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure
Michael E. J. Preedy
Sodium-Glucose Co-transporter 2 Inhibitors in the Failing Heart: a Growing Potential
Dulce Brito, Paulo Bettencourt, Davide Carvalho, Jorge Ferreira, Ricardo Fontes-Carvalho, Fátima Franco, Brenda Moura, José Carlos Silva-Cardoso, Rachel Tavares de Melo, Cândida Fonseca
Statin Controversies: Response to the Letter from Tomlinson et al.
Veronica Azemawah, Mohammad Reza Movahed, Patrick Centuori, Ryan Penaflor, Pascal L. Riel, Steven Situ, Mehrdad Shadmehr, Mehrnoosh Hashemzadeh
A Reconciliation Attempt of the Acute Coronary Syndrome Clinical Trials on Clopidogrel, Prasugrel, and Ticagrelor
Wim J. R. Rietdijk, Loes Mandigers, Corstiaan A. den Uil